CellMax Life is conducting a decentralized clinical research study to gather more information about the efficacy of a Blood Sample Test in identifying the presence of colorectal cancer (CRC) and advanced precancerous lesions (APL) that may cause cancer in the future.

The CellMax First Sight Colorectal Cancer Screening Test is completed in the privacy and comfort of your own home by a home health study nurse. The blood sample is collected within 60 days before a scheduled preventative colonoscopy. Eligible study participants will receive compensation.

​

To participate in this study, patients must: 

• Be between the ages of 45 and 85.

• Have been advised to have or have scheduled a screening colonoscopy or have suspected CRC or APL.

• After providing a blood sample, be willing to undergo a colonoscopy and willing to grant access to the resulting medical report.

• Be at average risk for CRC.

  • No prior history of malignancies, Ulcerative Colitis or Crohn's Disease.

  • No family history of Familial Adenomatous Polyposis, Hereditary Nonpolyposis Colorectal Cancer, or other Hereditary Cancer syndromes.

​

This study is actively enrolling. For more information and to see if you qualify,

​

email: CellMaxVRG@premier-research.com

or call: 1 (833) 958-0014